273 related articles for article (PubMed ID: 35076342)
1. Emerging therapeutic targets for cardiac hypertrophy.
Winkle AJ; Nassal DM; Shaheen R; Thomas E; Mohta S; Gratz D; Weinberg SH; Hund TJ
Expert Opin Ther Targets; 2022 Jan; 26(1):29-40. PubMed ID: 35076342
[TBL] [Abstract][Full Text] [Related]
2. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
Balakumar P; Jagadeesh G
Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure.
Oka T; Komuro I
Circ J; 2008; 72 Suppl A():A13-6. PubMed ID: 18772527
[TBL] [Abstract][Full Text] [Related]
4. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
[TBL] [Abstract][Full Text] [Related]
5. CaMKII exacerbates heart failure progression by activating class I HDACs.
Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
[TBL] [Abstract][Full Text] [Related]
7. Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.
Wang Y; Keskanokwong T; Cheng J
J Mol Cell Cardiol; 2019 Jan; 126():77-85. PubMed ID: 30462989
[TBL] [Abstract][Full Text] [Related]
8. ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.
Blackwood EA; Hofmann C; Santo Domingo M; Bilal AS; Sarakki A; Stauffer W; Arrieta A; Thuerauf DJ; Kolkhorst FW; Müller OJ; Jakobi T; Dieterich C; Katus HA; Doroudgar S; Glembotski CC
Circ Res; 2019 Jan; 124(1):79-93. PubMed ID: 30582446
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
Ryall KA; Bezzerides VJ; Rosenzweig A; Saucerman JJ
J Mol Cell Cardiol; 2014 Jul; 72():74-84. PubMed ID: 24613264
[TBL] [Abstract][Full Text] [Related]
10. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
[TBL] [Abstract][Full Text] [Related]
11. Network reconstruction and systems analysis of cardiac myocyte hypertrophy signaling.
Ryall KA; Holland DO; Delaney KA; Kraeutler MJ; Parker AJ; Saucerman JJ
J Biol Chem; 2012 Dec; 287(50):42259-68. PubMed ID: 23091058
[TBL] [Abstract][Full Text] [Related]
12. Functions of autophagy in pathological cardiac hypertrophy.
Li Z; Wang J; Yang X
Int J Biol Sci; 2015; 11(6):672-8. PubMed ID: 25999790
[TBL] [Abstract][Full Text] [Related]
13. Automated image analysis identifies signaling pathways regulating distinct signatures of cardiac myocyte hypertrophy.
Bass GT; Ryall KA; Katikapalli A; Taylor BE; Dang ST; Acton ST; Saucerman JJ
J Mol Cell Cardiol; 2012 May; 52(5):923-30. PubMed ID: 22142594
[TBL] [Abstract][Full Text] [Related]
14. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
15. Macrophage microRNA-155 promotes cardiac hypertrophy and failure.
Heymans S; Corsten MF; Verhesen W; Carai P; van Leeuwen RE; Custers K; Peters T; Hazebroek M; Stöger L; Wijnands E; Janssen BJ; Creemers EE; Pinto YM; Grimm D; Schürmann N; Vigorito E; Thum T; Stassen F; Yin X; Mayr M; de Windt LJ; Lutgens E; Wouters K; de Winther MP; Zacchigna S; Giacca M; van Bilsen M; Papageorgiou AP; Schroen B
Circulation; 2013 Sep; 128(13):1420-32. PubMed ID: 23956210
[TBL] [Abstract][Full Text] [Related]
16. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy.
Lieu M; Koch WJ
Expert Opin Ther Targets; 2019 Mar; 23(3):201-214. PubMed ID: 30701991
[TBL] [Abstract][Full Text] [Related]
17. Raf-mediated cardiac hypertrophy in adult Drosophila.
Yu L; Daniels J; Glaser AE; Wolf MJ
Dis Model Mech; 2013 Jul; 6(4):964-76. PubMed ID: 23580199
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA
Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
[TBL] [Abstract][Full Text] [Related]
19. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Watson CJ; Horgan S; Neary R; Glezeva N; Tea I; Corrigan N; McDonald K; Ledwidge M; Baugh J
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):127-37. PubMed ID: 26130616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
